19th Jan 2023 07:39
(Sharecast News) - Dr Martens warned on profits on Thursday as the iconic bootmaker was hit by operational issues at its Los Angeles distribution centre and weaker trading in the US direct-to-consumer segment.
Read more24th Nov 2022 07:03
(Sharecast News) - Shares in Dr Martens slumped on Thursday as the famous UK shoe brand warned of lower core profit margins after interim profit fell on weaker direct-to-consumer sales in the second quarter and said it would raise prices to offset inflation.
Read more23rd Aug 2022 12:04
(Sharecast News) - On the Beach was at the top of the list of director buys on Tuesday, after founder and chief executive officer Simon Copper picked up 1.53m shares in the company.
Read more14th Jul 2022 07:46
(Sharecast News) - Iconic bootmaker Dr. Martens reiterated its full-year guidance on Thursday as it said trading since the start of this financial year has been in line with its expectations.
Read more1st Jun 2022 07:04
(Sharecast News) - Dr Martens shares surged on Wednesday after the iconic bootmaker lifted its revenue guidance for next year as it posted a big jump in full-year pre-tax profits, driven by a "very strong" performance in the Americas and Europe, the Middle East, and Africa.
Read more13th Apr 2022 09:36
(Sharecast News) - Analysts at Barclays cut their target price on iconic bootmaker Dr Martens from 480.0p to 360.0p on Wednesday but said it still sees as much as 50% upside to the stock's current price.
Read more27th Jan 2022 07:51
(Sharecast News) - Shares in bootmaker Dr Martens slumped early on Thursday despite it posting third-quarter group revenues that were in line with internal expectations amid slowing sales growth and a significant drop in sales across the Asia-Pacific region.
Read more6th Jan 2022 08:08
(Sharecast News) - Dr Martens tumbled on Thursday after private equity firm Permira sold 65m shares in the iconic bootmaker in a placing, which made up around 15% of its holdings.
Read more9th Dec 2021 07:23
(Sharecast News) - Iconic UK footwear brand Dr Martens posted a 46% rise in interim profits, driven by a recovery in physical stores sales as they reopened from Covid curbs, but warned that shipping delays in its US business due to supply chain constraints would continue into the next fiscal year.
Read more1st Dec 2021 08:23
(Sharecast News) - Barclays upgraded Dr Martens to 'overweight' from 'equalweight' on Wednesday, keeping the price target at 480p, as it argued that the iconic footwear company has an "attractive brand with many levers to drive revenue and EBITDA growth".
Read more29th Jul 2021 08:29
(Sharecast News) - Iconic boot maker Dr Martens said on Thursday that revenues jumped in the first quarter, with trading "slightly" ahead of its expectations and growth across all regions.
Read more13th Jul 2021 12:58
(Sharecast News) - Dr Martens: Goldman Sachs upgrades to buy with a target price of 535p.
Read more13th Jul 2021 09:43
(Sharecast News) - Goldman Sachs upped Dr Martens to 'buy' from 'neutral' on Tuesday, hiking the price target to 535p from 490p.
Read more21st Jun 2021 15:57
(Sharecast News) - Dr Martens revealed on Monday that non-executive director Robyn Perriss had acquired 20,000 ordinary shares in the FTSE 250-listed boot-maker.
Read more17th Jun 2021 07:36
(Sharecast News) - In its first results as a listed company, Dr Martens reported a jump in full-year revenue and earnings on Thursday thanks to solid online sales, as it reiterated its medium-term guidance.
Read more